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Abstract The purpose of the present studies was to 
examine representative uncompetitive and competitive 
NMDA antagonists, as welt as the glycine/NMDA 
antagonist, HA 966, in pigeons trained to discriminate 
either PCP or CGS 19755 from saline. Separate 
groups of pigeons were trained to discriminate either 
the uncompetitive, phencyclidine (PCP; 0.32 and 
1.0 mg/kg, IM), or the competitive, CGS 19755 (cis-4- 
phosphonomethyl-2-piperidine-carboxylic acid; 1.8 
mg/kg, IM), NMDA antagonists from saline. Un- 
competitive and competitive NMDA antagonists were 
examined in generalization studies, as were the race- 
mate and the (+) and (-) stereoisomers of HA 966 (3- 
amino-l-hydroxypyrrolid-2-one). Dizocilpine (MK 
801) was fully generalized to PCP but not to CGS 
19755. All competitive NMDA antagonists tested were 
fully generalized to CGS 19755, but not to PCR The 
competitive antagonists, however, produced >50% 
PCP-appropriate responding. The (+) isomer of HA 
966 was fully generalized by three of four pigeons dis- 
criminating PCP (1.0 mg/kg) or CGS 19755, whereas 
the racemate and the (-) isomer produced <40% drug- 
appropriate responding in either group. Neither 
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NMDA, morphine, nor pentobarbital produced > 10% 
drug-appropriate responding in either discrimination 
group. The competitive antagonists tended to produce 
peak drug-appropriate responding at times greater than 
60 min after administration, whereas uncompetitive 
antagonists produced peak drug-appropriate respond- 
ing at earlier times. HA 966 also had a relatively slow 
onset of action as compared to PCR These results sug- 
gest that antagonists acting at different modulatory 
sites of the NMDA receptor complex produce similar, 
but not identical, discriminative stimuli. 
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Introduction 
Recently, discriminative stimulus effects of competitive 
and uncompetitive N-methyl-D-aspartate (NMDA) 
receptor antagonists have been investigated in several 
species. Reports have described various levels of gen- 
eralization of discriminative effects of NMDA antago- 
nists. One might predict that compounds that act as 
antagonists at the NMDA receptor complex, regard- 
less of location of modulatory site of action, would 
produce similar discriminative stimulus effects. 
However, this result has not necessarily been the case. 
In animals trained to discriminate phencyclidine-like 
compounds, competitive antagonists produce full (e.g., 
Koek et al. 1987), partial (e.g., Tricklebank et al. 1989), 
or no (e.g., France et al. 1989) generalization. 
There have been fewer studies of discrimination tasks 
based upon competitive NMDA antagonists. Leander 
(1989) trained pigeons to discriminate the competitive 
NMDA antagonist CGS 19755 (Lehmann et al. 1988) 
from saline and reported that both competitive 
and uncompetitive NMDA antagonists were fully 
generalized. However, Willetts et al. (1989) reported 
that, in rats trained to discriminate another competi- 
tive antagonist NPC 12626 [2-amino-4, 5-(1, 2-cyclo- 
hexyl)-7-phosphonoheptanoic acid] (Ferkany et al. 
1989), a competitive antagonist, CPP [3-(2-carboxyp- 
iperazine-4-yl)-propyl-l-phosphonic acid], but not an 
uncompetitive antagonist, PCR was generalized to the 
training cue. In a continuation of the Willetts et al. 
study, Bobelis and Balster (1993) reported results 
similar to previous findings: the competitive NMDA 
antagonists CGS 19755, CPPene (D-3-(2-carboxyp- 
iperazin-4-yl)-l-propenyl-l-phosphonic acid), and 
CGP 37849 (DL-(E)-2-amino-4-methyl-5-phosphono- 
3-pentenoic acid) were generalized to the NPC 12626 
training cue, whereas the uncompetitive antagonists 
dizocilpine and dextromethorphan, up to doses which 
greatly reduced response rates, were not fully general- 
ized. Similar findings were reported in squirrel mon- 
keys (Gold and Balster 1993). These data, in part, 
suggest differences between the discriminative effects of 
NMDA antagonists. Less work has been done to inves- 
tigate the behavioral actions of compounds which act 
as antagonists at other modulatory sites on the NMDA 
receptor-complex. (+)-HA 966 is a glycine/NMDA 
antagonist which, when tested in rats trained to dis- 
criminate PCP from saline, was not generalized, nor 
was PCP generalized in rats discriminating (+)-HA 966 
from saline (Singh et al. 1990). The purpose of the pre- 
sent studies was to examine representative uncompet- 
itive and compe, titive NMDA antagonists, as well as 
the glycine/NMDA antagonist HA 966, in pigeons 
trained to discriminate either PCP or CGS 19755 from 
saline, in particular, focusing on both dose-effect eval- 
uations and time course studies of their discriminative 
effects. Two training doses of PCP were originally used 
to examine the effects of different training doses on gen- 
eralization patterns (Koek et al. 1987); some data from 
the continuation of those studies are included here. 
Materials and methods 
Subjects 
Fourteen naive White Carneaux pigeons (Palmetto Pigeon Plant; 
Sumter, S.C.) were maintained at 85% free-fe@ing weight with 
Purina Pigeon Chow supplemented with mixed-grain during exper- 
imental sessions. Mineral grit and water were freely available in the 
home cages. Pigeons were individually housed in a colony room 
maintained at approximately 72°F with a 16:8-h light:dark cycle. 
Apparatus 
Experiments were conducted in ventilated, sound-attenuated oper- 
ant chambers. Each chamber contained three 2.5 cm diameter 
response keys, located 5 cm apart, and 22 cm above the chamber 
floor. The keys could be transilluminated by 7-W lights directly 
behind each key. Mixed grain was made available via a 5 x 5 cm 
opening located directly below the center key. Experiments were 
controlled by IBM PCjr microcomputers, using BASIC program- 
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ming language, located in the room adjacent to the experimental 
chambers. 
Initial shaping 
All pigeons were initially trained to respond on a single, red-illu- 
minated key. Subsequently, 20 responses on a single key were 
required to produce food presentation. Four pigeons were trained 
to discriminate intramuscular injections of 0.32 mg/kg PCP from 
saline and four were trained to discriminate 1.0 mg/kg PCP from 
saline. Six pigeons were trained to discriminate IM injections of 
1.8 mg/kg CGS 19755 from saline. 
Discrimination training 
PCP 
After naive subjects were trained on a FR20 schedule of food-rein- 
forced responding on a single key, PCP and saline training com- 
menced. Initially, either IM PCP or saline was administered and 
subjects were placed in the experimental chambers. Four pigeons 
were trained to discriminate 0.32 mg/kg PCP from saline using pre- 
viously described procedures (Koek et al. 1987). In the other four 
pigeons, doses of PCP (0.32 or 0.56 mg/kg) lower than the ultimate 
training dose of 1.0 mg/kg were administered because this dose 
(1.0 mg/kg) initially reduced rates of responding. Lower doses were 
administered for several sessions until rates of responding appeared 
stable. The PCP dose was then increased to 1.0 mg/kg. A I0-min 
time-out (TO) period, in which no keys were lit and responses had 
no scheduled consequence, preceded a 30-rain response period in 
which a single key was lit: left key after PCP injections and right 
key after saline injections. During the response period, 20 responses 
on the lit key resulted in food presentation (4-s access to mixed 
grain), with 32 tbod-presentations available per session. Drug and 
saline training sessions were alternated daily as follows: S-D-S-D- 
S-S-D-D, where S=saline, and D=drug. After eight sessions in which 
a single key was lit (four PCP training sessions, and four saline 
training sessions), both keys were illuminated and training contin- 
ued until pigeons met criterion for nine of ten consecutive training 
sessions. Criterion was defined as fewer than 20 responses on the 
injection-inappropriate key prior to the first food presentation and 
_> 90% of total responses emitted on the injection-appropriate key. 
Subsequent test sessions were conducted after at least two consec- 
utive training sessions in which criterion was met (one under drug 
and one under saline training conditions). Sessions were conducted 
6 days per week. In experiments in which pigeons were trained to 
discriminate 0.32 mg/kg PCP, training conditions were the same as 
for the 1.0 mg/kg PCP training group. In these subjects compounds 
from several pharmacological classes were tested. Subsequently, the 
training dose was increased to 1.0 mgtkg (approximate re-training 
time was 1 month); the group of pigeons trained to discriminate 
1.0 mg/kg PCP from saline therefore included the four pigeons 
originally trained to discriminate 0.32 mg/kg PCP from saline and 
pigeons trained to discriminate 1.0 mg/kg PCP, as described in 
previous sections. 
CGS 19755 
The training procedure was similar to the training of the PCP 
discrimination. Pigeons were initially trained to a FR20 schedule 
of food-reinforced responding on a single key. A dose of 1.8 mg/kg 
IM CGS 19755 was chosen as one which approached cataleptic 
doses, but did not produce catalepsy in pigeons (Lu et aI. t992). 
CGS 19755 was administered IM and subjects were returned to 
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their home cages for 80 rain. Pigeons were then placed in the exper- 
imental chambers. Each session began with a 10-rain time-out in 
which no keys were lit, followed by a 30-rain response period with 
32 food presentations available. This schedule resulted in a total of 
a 90-min treatment time after administration of CGS 19755 prior 
to the start of response periods. This time was chosen a priori based 
upon the onset of action of the cataleptic effects of CGS 19755, in 
which peak cataleptic effects did not occur until 90 rain after admin- 
istration (Lu et al. 1992). Otherwise, the training schedule for four 
pigeons continued as in the PCP discrimination task described 
above. The two remaining pigeons were trained under a similar 
schedule; however, this schedule did not include training sessions 
in which only a single key was illuminated in order to make pre- 
liminary comparisons between training conditions. 
Testing 
Generalization tests could be conducted using either a single 30- 
rain response period in which conditions were the same as in the 
training session, except that 20 responses on either key resulted in 
access to mixed grain, or using a nmltiple-cycle test session employed 
for a cumulative-dosing procedure and time course determinations. 
Each cycle consisted of either a 10- or 20-rain TO and a 5-min 
response period in which both keys were illuminated and 20 
responses on either key resulted in 4-s access to mixed grain. Each 
response period ended after 5 min or ten food presentations, 
whichever occurred first. If a pigeon completed ten fixed-ratios in 
less than 5 rain, the keys and houselight were not illuminated and 
responses had no scheduled consequences. The next cycle would 
begin at the end of the 5-rain response period, regardless of the 
number of food presentations. The multiple-cycle schedule allowed 
for a cumulative-dosing schedule or a time sampling analysis of the 
drug-appropriate responding. For extended time course sampling 
(e.g., 4 h) subjects were returned to their home cages, with no food 
available, after completion of 2 h of consecutive multiple cycles. 
Three hours and 50 min after test drug administration, pigeons 
were removed from home cages and placed in the experimental 
chambers. At this time a single 10-rain TO/5-min response period 
cycle followed. 
In the case of time course analyses of dizocilpine in PCP-trained 
pigeons, dizocilpine was injected and subjects placed immediately 
in the experimental chamber; the first response period began 1 min 
later. Subsequently, response periods occurred at 15-min intervals 
after injection of dizocilpine. In pigeons trained to discriminate CGS 
19755, dizocilpine was tested under a cumulative dosing procedure 
with 20-min TO and 5-min response periods (i.e., 25-rain cycles). 
Drugs 
The following drugs were used: phencyclidine hydrochloride 
(PCP) and TCP (N:[1-(2-thienyl)cyctohexyl]piperidine hydro- 
chloride (National Institute on Drug Abuse, Rockville, Md.); 
cis-4-phosphonomethyl-2-piperidine carboxylic acid (CGS 19755; 
CIBA-Ceigy); 2-amino-5-phosphonovalerate (AP5), 2-amino-7- 
phosphonoheptanoate (AP7), and N-methyl-D-aspartate (NMDA) 
from Sigma (St Louis, Mo.); 2-amino-4,5-(1,2-cyclohexyl)-7-phos- 
phonoheptanoate (NPC 12626) was a generous gift from J. Willetts, 
Nova Pharmaceuticals (Baltimore, Md.); cis-(+)-4-((2H-tetrazol-5- 
yt) methyl)piperidine-2-carboxylic acid (LY 233053) was a gener- 
ous gift from P. Ornstein, Eli Lilly (Indianapolis, Ind.); dizocilpine 
maleate (MK 801; Merck-Sharpe and Dohme; N.J.); the racemate 
and the (+) and (-) isomers of 3-amino-l-hydroxypyrolid-2-one (HA 
966; National Institute on Drug Abuse, Rockville, Md.); morphine 
sulfate (Mallinckrodt, St Louis, Mo.); and sodium pentobarbital 
(Gaines Chemical Works, New York, N.Y.). 
PCP, TCP, dizocilpine, and morphine and were dissolved in 
saline. Pentobarbital was dissolved in a solution of 10% ethanol, 
40% propylene glycol, and the remainder distilled water. NMDA, 
CGS 19755, AP5, AP7, NPC 12626, LY 233053, and HA 966 were 
dissolved in water and minimal amounts of NaOH, and titrated to 
neutral pH with lactic acid. All drugs were administered IM 
(1.0 ml/kg) into the breast muscle. 
Data analysis 
Data are represented as the mean (+ SE) of drug-appropriate (PCP 
or CGS 19755) responding and the mean (+_+_ SE) responses per sec- 
ond. In each discrimination task, dose-response functions for the 
competitive NMDA antagonists were calculated from data obtained 
in time course studies; i.e., each data point was chosen from the 
time (cycle) that a given dose produced the maximal group mean 
drug-appropriate responding (DAR) during which two or more sub- 
jects were responding; the associated rates of responding are also 
included. 
Reported ED50s were calculated using the procedure # 8 of 
Pharmacological Calculation System of Tallarida and Murray 
(1987). This procedure does not exclude data points less than 20% 
or greater than 80% effect levels. 
Results 
CGS 19755 discrimination 
The number of sessions required for pigeons to learn 
to discriminate 1.8 mg/kg IM CGS 19755 from saline 
ranged from 21 to 41 sessions (27 + 4.8; mean + SE). 
Two subjects which did not receive injections in asso- 
ciation with only the single, injection-appropriate key 
illuminated learned the discrimination in 24 and 54 
training days, respectively. One subject later died for 
experimentally unrelated reasons; data from five sub- 
jects are presented. 
CGS 19755 was dose-dependently generalized by all 
subjects with an ED50 of 0.92 mg/kg (0.74-1.14; 95% 
confidence limits). When tested over time, the training 
dose of CGS 19755 (1.8 mg/kg) was fully generalized 
90 min after administration. Greater than 90% CGS 
19755-appropriate responding was observed 4 h 
after administration; drug-appropriate responding 
decreased to below 40% by 8 h after administration 
(Fig. 1). Saline never produced > 10% CGS 19755- 
appropriate responding over 8 h (Fig. 1). The train- 
ing dose of PCP (1.0 mg/kg) was tested over time as 
a training-dose cross-generalization test in pigeons 
trained to discriminate CGS 19755. Peak effects of 
1.0 mg/kg PCP were obtained 15-30 min after admin- 
istration, but the group mean of drug-appropriate 
responding was never greater than 35% (Fig. 1). CGS 
19755-1ike responding produced by PCP did not occur 
at times after 60 min after administration. 
Generalizations 
Dizocilpine produced no CGS 19755-1ike responding 
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Fig. t Upper panel presents percentage of CGS 19755-appropriate 
responding and lower panel response rates (responses/s) after 
administration of 1.8 mg/kg CGS 19755 (V), 1.0 mg/kg PeP (V), 
and 1 ml/kg saline (0) as a function of time (rain) in pigeons trained 
to discriminate CGS 19755 from saline. Each point represents the 
mean (+ SE) of observations in five pigeons 
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(Fig. 2). Greater than 50% DAR was produced by PCP 
only at doses at which three subjects failed to respond 
(Fig. 2). All competitive NMDA antagonists were 
dose-dependently generalized; each produced group 
means greater than 90% DAR. However, NPC 12626, 
AP7, and LY 233053 produced _> 90% DAR at doses 
at which one subject did not respond (Fig. 2 and 
Table 1). AP7 was generalized in three subjects; the 
fourth pigeon did not respond at doses and times at 
which other pigeons generalized AP7. 
Neither the racemate, nor the (-) isomer of the 
gtycine/NMDA antagonist HA 966, produced greater 
than 35% drug-appropriate responding (Fig. 2). Each 
compound was generalized in one of four subjects 
(Table 1). (+)-HA 966 produced greater than 80% 
DAR at a dose of 100.0 mg/kg (Fig. 2) and was 
fully generalized in three of four subjects tested 
(Table 1). 
Neither NMDA, morphine, nor pentobarbital pro- 
duced greater than 5 % DAR (Table I) when examined 
in the CGS 19755-trained pigeons. 
Time course 
Times of peak effect of drug-appropriate responding 
for various compounds were determined in the 
following manner: the cycle (e.g., cycle 3 = 45 min) 
during which the group mean of drug-appropriate 
responding was largest was selected as the time of peak 
effect of that particular dose. The corresponding rates 
of responding during that cycle would also be reported. 
For example, if in three cycles the group mean DAR 
values were 10%, 85%, and 78%, respectively, and the 
group mean response rates were 2.5, 1.8, and 1.9 
Fig. 2 Upper panel present 
percentage of CGS 19755- 
appropriate responding and 
lower panels present response 
rates (responses/s) after 
administration of various 
NMDA antagonists as a 
function of dose (mg/kg) in 
pigeons trained to discriminate 
1.8 mg/kg CGS 19755. Points 
over "S" represent responding 
after administration of saline. 
Numbers in parentheses in 
upper panels represent the 
number of subjects responding 
at rates >0.2 responses/s; mean 
CGS 19755-appropriate 
responding is calculated using 
data from these subjects only 
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Table 1 Summary of time-course cross-generalization tests in the 
CGS 19755 (1.8 mg/kg) discrimination. N.D. not determinable 
from data as maximal DAR was 0%. N.A. not applicable as time 
course data were not determined for NMDA, morphine, or 
pentobarbital 
Drug Dose range Subst n/N a Max. % dar Max % darc Rate R/s d Time ~ Max. rate f Timeg 
tested mg/kg dose b 
NPC 12626 1-32 4/4 32 99.5 1.7 75 0.74 120 
(0.5) (0.8) (0.5) 
AP5 10-180 4/4 32 93.3h 3.1 75 1.6 120 
(3) (0.3) (0.7) 
AP7 10-100 3/4* 100 92.2 2.1 45 0.3 120 
(4) (1) (0.3) 
LY233053 10-I80 5/5 100 94.7 2.7 30 0.9 75 
(4) (0.7) (0.5) 
HA 966 3.2-32 1/4 3.2 32.5 3.1 105 0 90 
(21) (0.6) (0) 
(---)HA 966 1 10 1/4 10 27.5 1.9 75 0.1 90 
(20) (0.3) (0.1) 
(+)HA 966 3.2-100 3/4 100 82.5 2.5 60 1A 120 
(7.5) (0,1) (0.6) 
NMDA 1 10 0/3 N.D. 0 N.D. N.A. 0 N.A. 
(0) (0) 
Morphine 0.1-10 0/3 3.2 1.1 2.1 N.A. 0 N.A. 
(0.9) (0.4) (0) 
PentobarbitaI 1 18 0/3 N.D. 0 N.D. N.A. 2.12 N.A. 
(0) (1.1) 
a Number (n) of pigeons emitting _> 90% DAR at any dose/number (N) pigeons tested 
bDose which produced maximum mean % CGS 19755 appropriate responding 
c Maximum % CGS 19755 appropriate responding 
dResponses per second over the 5-min response periods obtained after administration of the dose resulting in maximum % DAR 
~Time (minutes after test drug administration) at which pigeons emitted maximum %DAR 
fLowest rate of responding obtained at the maximum dose tested 
gTime (minutes after test drug administration) at which pigeons emitted lowst rates of responding 
h AP5 180 mglkg produced slightly higher %DAR than did 32 mg/kg; however rates of responding were later (15-30 min) significantly 
decreased 
responses/s the data obtained during the second cycle 
would be reported in the dose-response function, i.e., 
85% D A R  and 1.8 responses/s. Thus, dose-response 
functions for each test compound  for both  D A R  and 
rates o f  responding were composed  f rom data  f rom the 
cycle in which peak group mean D A R  effect was 
obtained. By using this method,  values obtained for 
each point  in a given dose-response curve do not  nec- 
essarily correspond to the same times after adminis- 
tration. However, corresponding D A R  and response 
rates at any given dose were taken from the same cycle. 
Tables 1 and 2 contain the times o f  peak effect of  the 
dose of  test compound  which produced the group-max- 
imum level o f  DAR.  AP5 (Fig. 3) produced maximum 
group mean CGS 19755-1ike responding 75 min after 
administration, whereas AP7 and LY 233053 produced 
maximum effects 45 and 30 rain after  administration, 
respectively (Table 1). Each competit ive N M D A  
antagonist  greatly reduced rates of  responding at the 
maximum dose tested; N P C  12626, AP5, and AP7 sup- 
pressed rates 2 h after administration, whereas LY 
233053 caused the greatest reduction o f  rates o f  
responding after 75 min (Table 1). (+) -HA 966 
produced maximal D A R  60 min after administration; 
the same dose also produced the greatest rate reduc- 
tion after t20 min (Fig. 3). 
PCP discrimination 
Training dose - 0.32 mg/kg  
Using a cumulative dosing procedure, only uncompet-  
itive N M D A  antagonists were fully generalized in 
pigeons trained to discriminate 0.32 mg/kg PCP from 
saline (Table 2). Neither  morphine  nor  pentobarbi ta l  
was generalized in any subject. Discriminative stimu- 
lus effects of  the competitive N M D A  antagonists AP5 
and CGS 19755 were examined over time (30-105 min 
after administration) using the multiple-cycle testing 
procedure. AP5 was generalized in three of  four sub- 
jects and CGS 19755 was generalized in three o f  six 
subjects (Table 3). Max imum mean PCP-appropria te  
responding produced by AP5 and CGS 19755 was 
obtained 105 and 90 min after injections, respectively. 
Response rates were suppressed by the largest doses 90 
min after injection o f  AP5, and 75 min after injection 
of  CGS 19755. 
Training dose 1.0 mg/kg  
Using a cumulative dosing procedure, bo th  PCP and 
dizocilpine were fully generalized to the PCP training 
Fig. 3 Upper panels present 
percentage of CGS 19755- 
appropriate responding and 
lower panels response rates 
(responses/s) after 
administration of various 
doses of AP5 (left panels) and 
(+)-HA 966 (right panels) as a 
function of time (min) in 
pigeons trained to discriminate 
1.8 mg/kg CGS 19755. Points 
over "4H" represent 
responding measured 4 h after 
administration of the 
compounds 
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dose in all pigeons. Dizocilpine was approximately 
3-fold more potent in producing discriminative stimu- 
lus and rate suppressing effects than PCP (Fig. 4). 
None of the competitive antagonists produced __ 90% 
PCP-like responding in all subjects at similar doses 
and times. CGS 19755 resulted in four of four subjects 
responding _> 90% DAR; however, this was not neces- 
sarily dose-dependent and did not occur at similar 
times (Fig. 4; Table 3). Nevertheless, three of four 
pigeons distributed >_90% of all responses on the 
drug-appropriate key after administration of AP5 
(0.32 mg/kg PCP training dose), AP7, and LY 233053, 
which produced maximal DAR of 81.9%, 93.1%, 
and 46%, respectively (Fig. 4 and Table 3). The 
percent DAR of 93.1 produced by AP7 (100.0 mg/kg) 
is calculated from data from three pigeons only, as one 
pigeon did not respond at this time at this dose. 
The racemate of the glycine/NMDA antagonist HA 
966 was generalized by two of four pigeons and pro- 
duced a maximal DAR of 32.5%, whereas the (-) iso- 
mer was not generalized by any pigeons when 
administered up to a rate-suppressing dose (Fig. 4 and 
Table 3). The (+) isomer (100.0 mg/kg) was fully gen- 
eralized by all pigeons which responded (i.e., three of 
four), producing a maximum of 96.7% DAR. The 
apparent order of potency of the racemate and isomers 
of HA 966 in reducing rates of responding was (--)-HA 
966 > (+)-HA 966 > (+)-HA 966. 
T a b l e  2 Summary of 
cross-generalization tests in 
phencyclidine (0.32 mg/kg) 
discrimination: N.D. not 
determined, the test drug did 
not produce greater than 0% 
DAR at any dose tested. 
Drug Doses Subst n/N b Max. % dar Max. % dar d Rate Rate max 
tested a dose c R/S e dose f 
PCP 0.1-1.8 6/6 t 95 2.1 0.8 
(2.9) (0.4) (0.3) 
TCP 0.01-t 3/4 0.32 99.7 2.6 0.05 
(0.3) (0.5) (0.05) 
Dizocilpine 0.01 1 5/5 0.32 100 1.7 0 
(0) (0.2) (0) 
Morphine 0.1-1.8 0/4 N.D. 0 N.D. 0.05 
(0) (0.05) 
Pentobarbital 1-18 0/4 18 26.4 0.9 0.9 
(14) (0.5) (0.5) 
aDose range tested, mg/kg 
bNumber pigeons (n) emitting _> 90% DAR at any dose/number of pigeons (N) tested 
~Dose which produced the maximum mean % DAR 
d Maximum mean % D A R  (numbers in parentheses are one standard error). 
e Rate of responding (responses/s) over 5-rain response period obtained after cumulative-dose 
administration of  the dose resulting in maximum DAR 
fRate of responding (responses/s) over 5-rain response period at the highest dose tested 
48 
Table 3 Summary of time-course cross-generalization tests in phencyclidine (1.0 mg/kg) discrimination. N.D. 
2 subjects responded at this dose at this time 
determined as only 
Drug Dose range Subst n/N a Max. % dar Max % dar ° Rate R/s d Time ~ Max rate f Time g 
tested dose b 
Dizocilpine 0.1-1.0 4/4 0,32 100 2.14 75 0 l 5 
(0,8) (0) 
CGS 19755 0,1-5.6 4/4 3.2 66.5 1.27 120 0 90 
(33.2) (0.4) (0) 
NPC 12626 3.2-32 2/4 32 54.6 2.41 60 0.0 90 
(24) (0.7) (0) 
AP7 10-100 3/4 100 93.1 0.9 120 0.6 120 
(5) (,3) (0.4) 
LY 233053 10-180 3/4 180 46 1,83 45 0 45 
(21) (0.7) (0) 
HA 966 1 32 2/4 3.2 26.95 2.8 105 0 90 
(21) (0.4) (0) 
( - ) H A  966 1-10 0/4 10 8,3 0.2 75 0 90 
(ND) (0.1) (0) 
(+)HA 966 1-100 2/4 3.2 96.7 1,1 90 1.1 90 
(3.3) (0.6) (0,6) 
AP5 h 1 180 3/4 100 81.9 1.6 105 0 90 
(ND) (ND) (0) 
CGS 19755 h 0.032-5.6 3/6 3,2 76,2 1,4 90 0 75 
(12.6) (0.4) (0) 
~Number (n) of pigeons emitting > 90% DAR at any dose/number (N) pigeons tested 
b Dose which produced maximum mean % CGS 19755-appropriate responding 
c Maximum % CGS 19755-appropriate responding 
dResponses per second over the 5-min response periods obtained after administration of the dose resulting in maximum % D A R  
eTime (minutes after test drug administration) at which pigeons emitted maximum % D A R  
Lowest rate of responding obtained at the maximum dose tested 
gTime (minutes after test drug administration) at which pigeons emitted lowest rates of responding 
hAP5 and CGS 19755 were tested in pigeons trained to discriminate 0.32 mg/kg PCP: time samples were 30 to 105 rain after 
administration of AP5. 
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Time course 
Doses of dizocilpine greater than 0.1 mg/kg produced 
>50% PCP-appropriate responding 15 min after 
administration; however, group peak effect did not 
occur until 75 min after administration (Fig. 5). When 
>_50% of subjects responded, peak effect DAR of 
the maximally effective doses of all the competitive 
NMDA antagonists, except LY 233053, occurred 60 
min or later after administration (Table 3). CGS 19755 
Fig. 5 Upper panels present 
percentage of PCP-appropriate 
responding and lower panels 
response rates (responses/s) 
after administration of  various 
doses of dizocilpine (leJ~ 
panels), CGS 19755 (middle 
panels'), or (+)-HA 966 (right 
panels), as a function of  time 
(min) in pigeons trained to 
discriminate 1.0 mg/kg PCP. 
Points over "4H" represent 
responding measured 4 h after 
administration of  the 
compounds 
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produced peak DAR at times at which rate-decreasing 
effects were also observed (i.e., _> 60 min post-admin- 
istration, Fig. 5). LY 233053 produced a maximal 
group mean percent DAR 45 rain after administration. 
Competitive antagonists (excluding AP7) were also 
tested up to doses that completely suppressed respond- 
ing; peak DAR effects occurred > 90 rain after admin- 
istration (Table 3). LY 233053 produced a relatively 
rapid onset of action of rate-suppressing effects, as we11, 
with peak effects occurring 45 rain after administra- 
tion. (+)-HA 966 was generalized in all subjects which 
responded (i.e., three of four) at a dose of 100.0 mg/kg, 
with peak effects occurring 90 rain after administra- 
tion. The peak PCP-like effects produced by (+)-HA 
966 were also associated with peak rate-decreasing 
effects (Fig. 5 and Table 3). 
Discussion 
The competitive NMDA antagonist CGS 19755 
(1.8 mg/kg, IM) was readily trained as a discriminative 
stimulus in pigeons and was dose-dependently gener- 
alized as reported previously (Butelman et al. 1993). 
CGS 19755 produced a discriminative stimulus that was 
similar to those produced by other competitive antag- 
onists, but could be differentiated from those stimulus 
effects produced by the uncompetitive antagonists PCP 
and dizocilpine; PCP and dizocilpine produced <50% 
or no CGS 19755-appropriate responding, respectively. 
In contrast, CGS 19755 produced >50% PCP-appro- 
priate responding at doses which did not significantly 
decrease rates of responding. These results are similar 
to those reported previously (Willetts et al. 1989; 
Bobelis and Balster 1993) in which rats were trained 
to discriminate NPC 12626; CPR CPPene and CGS 
19755 were generalized completely, whereas PCP pro- 
duced <50% mean drug-appropriate responding. The 
discriminative stimulus effects of uncompetitive 
NMDA antagonists have been more widely studied 
than those of competitive NMDA antagonists (e.g., 
McMillan and Hardwick 1986; Koek et al. 1987; 
Jackson and Sanger 1988), and are now widely accepted 
to be mediated via antagonist activity at the NMDA- 
type receptors (e.g., Balster and Willetts 1988; Jackson 
and Sanger 1988; see also Woods et al. 1991). Generally, 
compounds that act as uncompetitive antagonists pro- 
duce discriminative stimulus effects to which other 
uncompetitive antagonists are generalized (e.g. Koek 
et al. 1988; Willetts and Balster 1988; Tricklebank et al. 
1989). In the present study, the uncompetitive NMDA 
antagonists tested were generalized to the PCP dis- 
criminative stimulus, regardless of training dose of PCR 
Previously, Koek et al. (1987) examined the effects of 
PCR AP5, and metaphit, a proposed PCP-site acyla- 
tor (Contreras et al. 1986), in separate groups of 
pigeons trained to discriminate different training doses 
of PCP from saline. The authors reported that 
progressively decreasing the training dose of PCP from 
1.0 mg/kg to 0.32 mg/kg increased the potencies of 
the compounds in substituting for the discriminative 
stimulus without losing selectivity of the discriminative 
effects. The results shown here present a similar profile 
of action for the uncompetitive antagonist dizocilpine 
in the high-or low-dose training conditions. However, 
CGS 19755 produced slightly different patterns of 
generalization in pigeons discriminating 0.32 or 
1.0 mg/kg PCE In the low-dose training group CGS 
19755 was generalized by three of six subjects tested, 
with peak DAR effects occurring 90 rain after admin- 
istration and peak rate effects occurring 75 rain after 
dosing, whereas in the high-dose training group, four 
of four subjects tested generalized to the training cue 
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with peak DAR and rate-reducing effects occurring 90 
and 120 rain after administration. However, potencies 
of drugs in producing peak DAR effects were not 
changed (Table 3). Although these are not large 
differences, it may be possible to use different training 
doses of PCP and/or CGS 19755 to examine differences 
between the stimulus effects of competitive NMDA 
antagonists. It is interesting to note that in the present 
studies the competitive NMDA antagonists presented 
a somewhat heterogenous profile of PCP-like discrim- 
inative effects. CGS 19755 was generalized in all 
pigeons, though not consistently at the same doses, 
whereas NPC 12626 was generalized by two of four 
subjects. It is not clear that these differences can be 
attributed to different onsets of action as it was 
observed that LY 233053, a compound with a slightly 
shorter onset of action, was generalized by three of 
four subjects tested. 
Earlier studies have reported that competitive 
NMDA antagonists such as CPP are not generalized 
to stimulus effects produced by PCP or dizocilpine 
(Jackson and Sanger 1988; Willetts and Balster 1988; 
Butelman et al. 1991). However, it was not always clear 
that the times of peak effect of the competitive antag- 
onists were examined within these studies. In rats 
trained to discriminate PCP from saline, Willetts and 
BMster administered AP7 IP 30 min prior to testing, 
and CPP 20 and 60 min prior to testing. The authors 
also administered AP7 intracerebroventricularly under 
the assumption that AP7 has poor access to brain when 
administered parenterally. The study of the onset of 
action of the cataleptic effects of many competitive 
antagonists in pigeons has found that, following sys- 
temic administration, catalepsy is not observed until 
90-120 rain after injection (Baron et al 1988; France 
et al. 1990), whereas central administration produces 
a rapid onset of catalepsy (Koek et al. 1987; France 
et al. 1990), suggesting that these compounds indeed 
have slow access to the brain. These data also suggest 
that other behavioral effects of these compounds should 
be examined over broader periods of time. 
The present time course studies revealed that the 
onset of discriminative stimulus effects of NMDA 
antagonists paralleled that of other behavioral effects 
produced by the same compounds. The competitive 
NMDA antagonists produced maximum drug-appro- 
priate responding and rate-decreasing effects in CGS 
19755-trained subjects at times which approximated 
those at which catalepsy occurs under other conditions 
(e.g., France et al. 1990; Lu et al. 1992). Other com- 
petitive antagonists, e.g., NPC 12626, produced simi- 
lar time courses of action: catalepsy was observed in 
pigeons 2 h after IM administration and was observed 
in some subjects after 8 h (France et al. 1990). PCP 
and dizocilpine produced relatively rapid onsets of dis- 
criminative stimulus effects which paralleled those 
observed for the cataleptic effects of these compounds 
(onset of 15-20 rain; Koek et al. 1986; Leander et al. 
1986; Lu et al. 1992). In the present experiments, the 
time courses of discriminative and rate-reducing effects 
of competitive antagonists were examined. Generally, 
after administration of competitive NMDA antago- 
nists, pigeons emitted significant PCP-like responding 
at times 60 rain after injection; high levels of PCP-like 
responding were also associated with decreased rates 
of responding. These results are consistent with those 
found by Butelman et al. (1991), in a study in which 
pigeons were trained to discriminate dizocilpine from 
saline: PCP was found to be fully generalized to the 
training stimulus, whereas CGS 19755 elicited >50% 
drug-appropriate responding at times later than 1 h 
and when rates of responding were greatly reduced. 
(+)-HA 966, a strychnine-insensitive glycine-site 
antagonist, has previously been shown to have antag- 
onist action at the NMDA/glycine modulatory site 
(e.g., Fletcher and Lodge 1988), to be an effective antag- 
onist of NMDA-induced convulsions and lethality 
(Koek and Colpaert 1990) and has been trained as a 
discriminative stimulus in rats (Singh et al. 1990). Singh 
et al. (1990) found that PCP produced little drug-appro- 
priate responding in rats discriminating (+)-HA 966 
and that (+)-HA 966 produced a maximum of 33% 
PCP-appropriate responding. The authors suggested 
that the differences between the discriminative effects 
of compounds acting as NMDA antagonists may 
depend upon the particular mechanism, or site of 
action, though which the antagonist action is con- 
ferred. In addition, the novel glycine-site antagonists 
ACEA 1011 and ACEA 1021 do not produce PCP-like 
effects in rats trained to discriminate PCP from saline 
(Balster et al. 1993). In contrast, the present experi- 
ments suggest a greater similarity in the discriminative 
effects of (+)-HA 966 to PCP and CGS 19755. 
In summary, the discriminative stimulus effects of 
NMDA antagonists acting at different sites within the 
NMDA-receptor macro-molecular complex were 
examined in pigeons trained to discriminate competi- 
tive (CGS 19755) or uncompetitive (PCP) NMDA 
antagonists, with particular attention to time course of 
discriminative effects. The present studies revealed that 
compounds which act to reduce activity at NMDA 
receptors elicited a greater percentage of drug-appro- 
priate responding than compounds which act though 
other pharmacological mechanisms, e.g., morphine and 
pentobarbital. However, NMDA antagonists acting at 
different sites of action do not produce identical dis- 
criminative stimulus effects. 
These are the most extensive studies of the 
time course of discriminative effects of these com- 
pounds to date. The current findings contrast with 
those of other studies, which have reported no 
significant generalization produced by uncompetitive 
antagonists in subjects trained to discriminate com- 
petitive antagonists, and vice versa. Earlier investiga- 
tions tested these compounds at time points which may 
not have represented times of peak effect. The current 
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studies indicate that, when examining the behavioral 
effects, time course of onset and duration of action 
should be considered. 
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